Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Brouwer PJM"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
Autorzy:
Larsen MD; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
de Graaf EL; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Sonneveld ME; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Plomp HR; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Nouta J; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Hoepel W; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Chen HJ; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Cardiovascular Sciences, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Linty F; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Visser R; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Brinkhaus M; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Šuštić T; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
de Taeye SW; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Bentlage AEH; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Toivonen S; Finnish Red Cross Blood Service, Helsinki, Finland.
Koeleman CAM; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Sainio S; Finnish Red Cross Blood Service, Helsinki, Finland.
Kootstra NA; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Geyer CE; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Derksen NIL; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Wolbink G; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.
de Winther M; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Cardiovascular Sciences, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.; Weill Medical College, Cornell University, New York, USA.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
de Bruin S; Department of Intensive Care Medicine, Amsterdam UMC (Location AMC), University of Amsterdam, Amsterdam, Netherlands.
Vlaar APJ; Department of Intensive Care Medicine, Amsterdam UMC (Location AMC), University of Amsterdam, Amsterdam, Netherlands.
Rispens T; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
den Dunnen J; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Zaaijer HL; Department of Blood-borne Infections, Sanquin, Amsterdam, Netherlands.
Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Ellen van der Schoot C; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Vidarsson G; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands. .; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Pokaż więcej
Corporate Authors:
Amsterdam UMC COVID-19
biobank study group
Źródło:
Science (New York, N.Y.) [Science] 2021 Feb 26; Vol. 371 (6532). Date of Electronic Publication: 2020 Dec 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Viral/*immunology
COVID-19/*immunology
Immunoglobulin G/*immunology
SARS-CoV-2/*immunology
Adult ; Aged ; Antibodies, Viral/blood ; Antibodies, Viral/chemistry ; COVID-19/physiopathology ; Cells, Cultured ; Critical Illness ; Cytomegalovirus/immunology ; Female ; Fucose/analysis ; Glycosylation ; HIV/immunology ; Hepatitis B Vaccines/immunology ; Humans ; Immunoglobulin Fc Fragments/chemistry ; Immunoglobulin Fc Fragments/immunology ; Immunoglobulin G/blood ; Immunoglobulin G/chemistry ; Inflammation ; Interleukin-6/biosynthesis ; Interleukin-6/immunology ; Macrophages/immunology ; Male ; Middle Aged ; Parvovirus B19, Human/immunology ; Severity of Illness Index ; Spike Glycoprotein, Coronavirus/immunology ; Vaccines, Subunit/immunology ; Young Adult
Czasopismo naukowe
Tytuł:
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.
Autorzy:
Antanasijevic A; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Ueda G; Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.
Brouwer PJM; Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands.
Copps J; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Huang D; Department of Immunology and Microbiology, Scripps Research, La Jolla, California, United States of America.
Allen JD; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Cottrell CA; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Yasmeen A; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Sewall LM; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.
Bontjer I; Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands.
Ketas TJ; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Turner HL; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Berndsen ZT; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Klasse PJ; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Crispin M; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Nemazee D; Department of Immunology and Microbiology, Scripps Research, La Jolla, California, United States of America.
Moore JP; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Sanders RW; Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands.
King NP; Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.
Baker D; Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Ward AB; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Aug 11; Vol. 16 (8), pp. e1008665. Date of Electronic Publication: 2020 Aug 11 (Print Publication: 2020).
Typ publikacji:
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
HIV Antibodies/*immunology
HIV Antigens/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Nanoparticles/*chemistry
env Gene Products, Human Immunodeficiency Virus/*chemistry
env Gene Products, Human Immunodeficiency Virus/*immunology
Animals ; Epitopes/immunology ; Female ; HIV Infections/virology ; Humans ; Immunization ; Nanoparticles/administration & dosage ; Rabbits ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Autorzy:
Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Caniels TG; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van der Straten K; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Snitselaar JL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Aldon Y; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bangaru S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Okba NMA; Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.
Claireaux M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Kerster G; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bentlage AEH; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.
van Haaren MM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Guerra D; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Burger JA; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Schermer EE; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Verheul KD; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van der Velde N; IBIS Technologies BV, 7521PR Enschede, Netherlands.
van der Kooi A; IBIS Technologies BV, 7521PR Enschede, Netherlands.
van Schooten J; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van Breemen MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bijl TPL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Sliepen K; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Aartse A; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.; Department of Virology, Biomedical Primate Research Centre, 2288GJ Rijswijk, Netherlands.
Derking R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bontjer I; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Wiersinga WJ; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Vidarsson G; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.
Haagmans BL; Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
de Bree GJ; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2020 Aug 07; Vol. 369 (6504), pp. 643-650. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*immunology
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Pneumonia, Viral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Aged ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Antibody Affinity ; Antigens, Viral/immunology ; B-Lymphocyte Subsets/immunology ; Broadly Neutralizing Antibodies/immunology ; COVID-19 ; Cell Line, Tumor ; Coronavirus Infections/prevention & control ; Coronavirus Infections/therapy ; Epitopes/immunology ; Female ; Humans ; Immunologic Memory ; Immunophenotyping ; Male ; Middle Aged ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/therapy ; Protein Domains ; Protein Interaction Domains and Motifs/immunology ; Receptors, Coronavirus ; Receptors, Virus/metabolism ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies